Forum Replies Created
-
Replies
-
Identification of stakeholders is guided by the scope of your trial and a look into the strata of stakeholders. My own experience is that stakeholders keep changing over time .But important to note in this is having a starting point as the inner stakeholders(Participants) then widen to the outer layers. What I see as always neglected are the trial site staffs.Why?
Leader & team ,
How many engagement trainings have your sites conducted that combined both internal and external stakeholders?
John ,
I am able to see your lesson input but how did you make it. my uploading has failed. What could be the problem? My computer competence is minimal.Hahahaha
GPP LESSON 1 ASSIGNMENT.1.1 Recognizing and acknowledging the importance of stakeholders in the research process starts from identification/mapping of these individuals, groups, organizations that can have an influence and can be affected by the process. This alone creates a basis for appreciating the importance of stake holders.
Stakeholders have been discovered to be end-users for the products of the research process. It is important that experimental HIV prevention options are tested for safety and efficacy in populations that require these interventions most and are potential consumers should there be licensure. For instance, the importation of male condoms from China to Uganda was affected by the fact that the size could not match with the average size of a Ugandan. There was lack of stakeholder engagement before importation.
Stakeholders contribute to the research process unique expertise in form of critical knowledge, understanding of societal issues, cultures, language and local priorities that are essential for the process. This puts stakeholders at one side with the research the other end. Hence, the need to combine competencies.
Bio-medical HIV prevention research is participatory in nature! This therefore calls for involvement of stakeholders as equal members/partners in the process and helping them to understand the context in which the process occurs.
Taking a historical perspective, bio-medical research lacked respect for fundamental human rights.Todate; involving human subject requires taking them as stakeholders meaning that they are an integral part of the process. The vivid example here is the Prep trials in Cambodia and Cameroon. The lesson we draw from this example is that there was no partnership.
Bio-medical HIV prevention trials are conducted in a defined environment, the community in its wider context. The community owners are the stakeholders whose presence can affect or have influence on the entire process.
Recognizing that research teams is another set of stakeholders (internal) whose team role in the process is critical in ensuring scientific and ethical integrity of the process. This makes them an important part of research process.
Overall, acknowledging the different layers of stakeholders in the bio-medical prevention research process makes stakeholders an integral part of the process with different layers playing unique roles. The importance in the process is derived from the unique roles.
1.2 The research team in the wider context is composed of different key players who contribute to the process in many ways. The extent of value in stakeholder engagement is usually limited to the level of interface with inner layers of the stakeholders. These include; Trial participants, CAB and research community.
This interface with the above mentioned make the research team defines the stakeholders to mean the above category alone. However, a few members of the team are able to value stakeholder engagement beyond this layer to the global outer layer.The active involvement of the above mentioned stakeholders in the research process make the passive stakeholders less valuable to the research team.
Even with the few valued stakeholders the value is perceived in terms of their potential to provide needed samples NOT how much they can influence.
Against this background, this creates a gap in promotion Of Good Participatory Practices (GPP) where team effort and support in needed. The teacher must be taught to teach!
Dear Team ,
Don’t miss out on the baseline evaluation. It was quite a brain teaser for me.Try it out. It is getting to week end in Uganda. Catch up on Monday.
Dear Leader ,
Nice Seeing that GPP is taking shape globally. Again learning about employing M&E tools in community engagement is exciting. Longing for that time when I can ably and routinely employ these tools.
Is there such an opportunity to share this during this training(GPP)? Looking forward!
Hello GPP Family ,
It is a pleasure joining you in this interaction!
Meet Mathias a community liaison officer with Uganda Virus Research Institute-International Aids Vaccine Initiative(UVRI-IAVI HIV Vaccine Program-Uganda).The Program is into phase 1 Vaccine trials at the site and field epidemiological studies in fishing communities in and along L.Victoria. These fishing communities are hard to reach with very limited access to health services.
I am at the forefront of all the community engagement activities that are research related ,out-reaches and collaborative efforts with service providers. This calls for many travels across waters with our Program boat.
Empowering me with GPP knowledge will take me an extra mile in cementing partnerships between researchers and stakeholders. I am happy having you as on-line classmates.
Looking forward to further interaction!
